Showing results (221-230 of 262) with videos related to
Sort By:
Pageof 27
Histopathology|February 28, 2023
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortiumYasodha Natkunam, Daphne de Jong, Pedro Farinha, et al.Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.Hemasphere|August 18, 2025
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working PartyPhilipp Berning, Maud Ngoya, Won Seog Kim, et al.Leukemia|August 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaborationFabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent LymphomaMartin Dreyling, Armando Santoro, Luigina Mollica, et al.Lancet (London, England)|May 30, 2026
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trialGeorg Lenz, Marek Trněný, John M Burke, et al.Blood Advances|April 9, 2025
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potentialMiriam Verdú-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro, et al.JAMA Oncology|February 9, 2023
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical TrialMartin Bornhäuser, Christoph Schliemann, Johannes Schetelig, et al.Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.Journal of Hematology & Oncology|December 2, 2022
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemiaNicole Bäumer, Annika Scheller, Lisa Wittmann, et al.Pageof 27